2017
DOI: 10.1016/j.drudis.2017.04.021
|View full text |Cite
|
Sign up to set email alerts
|

Development of nanomaterials for bone-targeted drug delivery

Abstract: Bone is one of the major organs of the human body; it supports and protects other organs, produces blood cells, stores minerals, and regulates hormones. Therefore, disorders in bone can cause serious morbidity, complications, or mortality of patients. However, despite the significant occurrence of bone diseases, such as osteoarthritis (OA), osteoporosis (OP), non-union bone defects, bone cancer, and myeloma-related bone disease, their effective treatments remain a challenge. In this review, we highlight recent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
85
0
2

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 117 publications
(87 citation statements)
references
References 154 publications
(229 reference statements)
0
85
0
2
Order By: Relevance
“…Their use resulted in most cases in reduced rate of complications, operative times, operative costs, and hospital length of stay, along with comparable or better results in term of clinical and radiological outcomes [8,[38][39][40][41]. Furthermore, xenohybrid materials demonstrated that can be successfully used as carriers to locally administer drugs or MSCs, making them a useful resource for orthopaedic surgeons, in a variety of conditions [7,20,44,45]. Hence, more clinical studies to better understand the role of biomaterials in orthopaedic surgery are encouraged.…”
Section: Discussionmentioning
confidence: 99%
“…Their use resulted in most cases in reduced rate of complications, operative times, operative costs, and hospital length of stay, along with comparable or better results in term of clinical and radiological outcomes [8,[38][39][40][41]. Furthermore, xenohybrid materials demonstrated that can be successfully used as carriers to locally administer drugs or MSCs, making them a useful resource for orthopaedic surgeons, in a variety of conditions [7,20,44,45]. Hence, more clinical studies to better understand the role of biomaterials in orthopaedic surgery are encouraged.…”
Section: Discussionmentioning
confidence: 99%
“…Lipid nanoparticles (LNPs), have great potential in comparison with inorganic nanoparticles, due to their biocompatibility and low toxicity. LNPs are uniform nano-carriers including solid- and liquid-state lipids, that can be organized into a core-shell or homogeneous particle structure [ 27 ]. They include lipid drug conjugate (LDC) carriers, nanostructured lipid carriers (NLCs), lipid nanocapsules carriers (LNCs) and solid lipid nanoparticle (SLN) carriers [ 28 ].…”
Section: Biomaterials For Bone Scaffoldsmentioning
confidence: 99%
“…MSN-based multifunctional drug delivery systems are able to deliver antitumor drugs in a targeted fashion and release them on demand to increment their cellular uptake without any premature release prior to reaching the target site [ 31 ]. They can accelerate bone formation by upregulating osteoblast activity and decreasing bone resorption by downregulating osteoclast activity; for this reason they are still a great option for treating osteoporosis [ 27 ].…”
Section: Biomaterials For Bone Scaffoldsmentioning
confidence: 99%
See 1 more Smart Citation
“…Fibrous nanomaterials are important for many potential applications including: wound dressing (Hassiba et al ., ); filtration, including air filtration (Al‐Attabi et al ., ); biosensors (Pasinszki et al ., ); tissue engineering such as skin tissue engineering (Jiang et al ., ) and targeted drug delivery to, e.g. bone (Cheng et al ., ). Fibres are also naturally occurring in plants, and in animals, see, e.g.…”
Section: Introductionmentioning
confidence: 97%